当前位置: 首页? 政策法规? 国外法规? REGULATION (EU) 2016/371:拒绝批准某些食品健康声称,不涉及降低疾病风险和儿童成长、健康有关的声称(refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health(/a>

REGULATION (EU) 2016/371:拒绝批准某些食品健康声称,不涉及降低疾病风险和儿童成长、健康有关的声称(refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health(/h1>
扫描二维 分享好友和朋友圈
放大字体缩小字体2016-03-18 01:22:09 来源9a href="http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2016.070.01.0012.01.ENG&toc=OJ:L:2016:070:TOC" target="_blank" rel="nofollow">欧盟浏览次数9span id="hits">5484
核心提示?016??6日,欧盟发布委员会条?EU) 2016/371,否?类健康声称、/div>
发布单位
欧盟委员
欧盟委员伙/div>
发布文号 REGULATION (EU) 2016/371
发布日期 2016-03-16 生效日期 2016-03-16
有效性状?/th> 废止日期 暂无
备注 2016??6日,欧盟发布委员会条?EU) 2016/371,否?类健康声称。InQpharm Europe Ltd、Natural Alternative International, Inc.等公司分别向欧盟提交申请,请求批准部分健康声称,经过欧盟食品安全局的评估,欧盟委员会均作出否决。具体如下:

营养或食品名?/b> 声称内容 欧盟食品安全局意见参耂/b>
發a href="//www.sqrdapp.com/news/tag_2335.html" class="zdbq" title="芸豆相关食品资讯" target="_blank" style="color: rgb(51, 51, 51); text-decoration: none;">芸豆水标准提取物 有助于减?/td> Q-2013-00973
-丙氨酷/td> 短时高强度锻炼期间提高运动效枛/td> Q-2013-00974
含活菌的脱脂酸奶或发酵乳,声?ldquo;无脂?ldquo;低糖?ldquo;高蛋?rdquo;?ldquo;钙源?ldquo;维D?rdquo; 有助于减少身体和内脏脂肪 Q-2014-00126
含活菌的脱脂酸奶或发酵乳,声?ldquo;无脂?ldquo;低糖?ldquo;高蛋?rdquo;?ldquo;钙源?ldquo;维D?rdquo; 添加维D不含糖,有助于减里/td> Q-2014-00127
Teestar?,葫芦巴籽提取物半乳甘露聚糖 降低血糖浓?/td> Q-2014-00153
COMMISSION REGULATION (EU) 2016/371
of 15 March 2016
refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods (1), and in particular the first subparagraph of Article 18(5) thereof,
Whereas:
(1)
Pursuant to Regulation (EC) No 1924/2006 health claims made on foods are prohibited unless they are authorised by the Commission in accordance with that Regulation and included in a list of permitted claims.
(2)
Regulation (EC) No 1924/2006 also provides that applications for authorisations of health claims may be submitted by food business operators to the national competent authority of a Member State. The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as the Authority, for a scientific assessment, as well as to the Commission and the Member States for information.
(3)
The Authority is to deliver an opinion on the health claim concerned.
(4)
The Commission is to decide on the authorisation of health claims taking into account the opinion delivered by the Authority.
(5)
Following an application from InQpharm Europe Ltd, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to a standardised aqueous extract from white kidney bean (Phaseolus vulgaris L.) and reduction of body weight (Question No EFSA-Q-2013-00973 (2)). The claim proposed by the applicant was worded as follows: Helps to reduce body weight.
(6)
On 16 July 2014, the Commission and the Member States received the scientific opinion from the Authority, which concluded that the evidence provided was insufficient to establish a cause and effect relationship between the consumption of the standardised aqueous extract from white kidney bean (Phaseolus vulgaris L.) and reduction of body weight. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.
(7)
Following an application from Natural Alternative International, Inc. (NAI), submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to beta-alanine and increase in physical performance during short-duration, high-intensity exercise (Question No EFSA-Q-2013-00974 (3)). The claim proposed by the applicant was worded as follows: Beta-alanine increases performance during short-duration high intensity exercise.
(8)
On 16 July 2014, the Commission and the Member States received the scientific opinion from the Authority, which concluded that a cause and effect relationship had not been established between the consumption of beta-alanine and increase in physical performance during short-duration, high-intensity exercise. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.
(9)
Following an application from Federacin Nacional de Industrias Lcteas (FeNIL), submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to fat-free yogurts and fermented milks complying with the specifications fat free, low in sugars, high protein, source of calcium and source of vitamin D for nutrition claims and reduction of body and visceral fat while maintaining lean body mass in the context of an energy-restricted diet (Question No EFSA-Q-2014-00126 (4)). The claim proposed by the applicant was worded as follows: Fat-free yogurts and fermented milks with live yogurt cultures, with added vitamin D, and with no added sugars, help to reduce body and visceral fat in the context of an energy-restricted diet.
(10)
On 7 January 2015, the Commission and the Member States received the scientific opinion from the Authority, which concluded that a cause and effect relationship had not been established between the consumption of fat-free yogurts and fermented milks with live yogurt cultures complying with the specifications fat free, low in sugars, high protein, source of calcium and source of vitamin D for nutrition claims and reduction of body and visceral fat while maintaining lean body mass in the context of an energy-restricted diet. In that opinion, the Authority also noted that no human studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.
(11)
Following an application from Federacin Nacional de Industrias Lcteas (FeNIL), submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to fat-free yogurts and fermented milks with live yogurt cultures complying with the specifications fat free, low in sugars, high protein, source of calcium and source of vitamin D for nutrition claims and maintenance of lean body mass in the context of an energy-restricted diet (Question No EFSA-Q-2014-00127 (5)). The claim proposed by the applicant was worded as follows: Fat-free yogurts and fermented milks with live yogurt cultures, with added vitamin D, and with no added sugars, help to maintain lean body mass (muscle and bone) in the context of an energy-restricted diet.
(12)
On 7 January 2015, the Commission and the Member States received the scientific opinion from the Authority, which concluded that a cause and effect relationship had not been established between the consumption of fat-free yogurts and fermented milks with live yogurt cultures complying with the specifications fat free, low in sugars, high protein, source of calcium and source of vitamin D for nutrition claims and maintenance of lean body mass in the context of an energy-restricted diet. In that opinion, the Authority also noted that no human studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.
(13)
Following an application from Avesthagen Limited, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to Teestar?, a fenugreek seed extract standardised by its content of galactomannan, and a reduction of post-prandial glycaemic responses (Question No EFSA-Q-2014-00153 (6)). The claim proposed by the applicant was worded as follows: Teestar? lowers blood glucose levels.
(14)
On 8 January 2015, the Commission and the Member States received the scientific opinion from the Authority, which concluded that a cause and effect relationship had not been established between the consumption of Teestar?, a fenugreek seed extract standardised by its content of galactomannan, and a reduction of post-prandial glycaemic responses. In that opinion, the Authority also noted that in the absence of evidence for an effect of Teestar? on post-prandial glycaemic responses in humans, animal studies on potential mechanisms do not provide support for the scientific substantiation of the claim. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.
(15)
The comments from the applicants received by the Commission pursuant to Article 16(6) of Regulation (EC) No 1924/2006 have been considered when setting the measures provided for in this Regulation.
(16)
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS REGULATION:
Article 1
The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.

ANNEX

Rejected health claim

Application Relevant provisions of Regulation (EC) No 1924/2006

Nutrient, substance, food or food category

Claim

EFSA opinion reference

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Standardised aqueous extract from white kidney bean (Phaseolus vulgaris L.)

Helps to reduce body weight

Q-2013-00973

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Beta-alanine

Beta-alanine increases performance during short-duration high intensity exercise

Q-2013-00974

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Fat-free yogurts and fermented milks with live yogurt cultures complying with the specifications fat free, low in sugars, high protein, source of calcium and source of vitamin D for nutrition claims

Fat-free yogurts and fermented milks with live yogurt cultures, with added vitamin D, and with no added sugars, help to reduce body and visceral fat in the context of an energy-restricted diet

Q-2014-00126

地区9/font>欧盟
标签9/font>疾病风险声称健康声称
食品伙伴网提供标准法规解读、舆情监控、合规咨询、申报注册等服务、br/>电询?535-2129301
QQ?891238009
食品标法? border=
实时把握 食品标法动?/span>
请扫码关?span class="color2">食品标法圇/span>

声明9/p>

凡本网所有原?编译文章及图片、图表的版权均属食品伙伴网所有,如要转载,需注明“信息来源:食品伙伴网”、br> 凡本网注明“信息来源:XXX(非食品伙伴网)”的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责、br> 邮箱:law#www.sqrdapp.com(发邮件时请?换成@ QQ?39307733

[ 政策法规搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]

Baidu
map